Common Contracts
6 similar Registration Rights Agreement contracts by Argos Therapeutics Inc, Aclaris Therapeutics, Inc., Clearside Biomedical, Inc., Sphere 3D Corp
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 5th, 2020 • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of November 22, 2017 by and among Argos Therapeutics, Inc., a Delaware corporation (the “Company”), and Saint-Gobain Plastics Performance Corporation, a California corporation (“Saint-Gobain”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 25th, 2019 • Clearside Biomedical, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of November 22, 2019 by and among Clearside Biomedical, Inc., a Delaware corporation (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 28th, 2017 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of November 22, 2017 by and among Argos Therapeutics, Inc., a Delaware corporation (the “Company”), and Saint-Gobain Plastics Performance Corporation, a California corporation (“Saint-Gobain”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 25th, 2017 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 22, 2017 by and among Argos Therapeutics, Inc., a Delaware corporation (the “Company”), and Invetech Pty Ltd (“Invetech”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 2nd, 2016 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 27, 2016 by and among Aclaris Therapeutics, Inc., a Delaware corporation (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 2nd, 2015 • Sphere 3D Corp • Services-computer processing & data preparation • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into as of this [●] day of May, 2015, by and among Sphere 3D Corp., an Ontario corporation (the “Company”) and the “Investors” named in that certain Purchase Agreement dated as of the date hereof, by and among the Company and MacFarlane Family Ventures, LLC (the “Initial Purchase Agreement”); provided, that on or after the date of this Agreement until the date that is forty-five (45) days after the date of the Initial Purchase Agreement, the Company may (in its sole discretion) add additional parties to this Agreement as “Investors” hereunder and additional Registrable Securities, provided that on or after the date of this Agreement until the date that is forty-five (45) days after the date of the Initial Purchase Agreement, such additional Investors execute and deliver a counterpart signature page to this Agreement and purchase Common Shares (as defined below) (“Additional Common Shares”) and/or warrants to purch
